Analysis of Hematological and Biochemical Parameters in Rheumatoid Arthritis Patients from Faisalabad, Punjab
Hematological and Biochemical Parameters in Rheumatoid Arthritis Patients
DOI:
https://doi.org/10.54393/pjhs.v6i2.1999Keywords:
Rheumatoid Arthritis, Potential Markers, White Blood Cells, Erythrocyte Sedimentation RateAbstract
Rheumatoid Arthritis (RA) is a long-term autoimmune disease that causes inflammation and joint degeneration. It can lead to significant impairment and a loss in quality of life for millions of people worldwide. When diagnosing and treating RA, hematological and biochemical indicators are frequently assessed. These data are essential for monitoring the disease's progression, identifying organ involvement, and making treatment decisions. Objectives: To come up with some significant differences in hematological and biochemical indicators between patients with RA and healthy controls for the diagnosis of RA. Methods: Three hundred blood samples were taken in total from the population of Faisalabad City; 150 blood samples were drawn from people who have been confirmed diagnosed with RA, and 150 blood samples were collected from healthy people without any disease. The significant levels between the two groups were ascertained by calculating descriptive statistics and statistical comparisons using independent t-tests for continuous variables. Results: Among assessed parameters, erythrocyte sedimentation rate (ESR) and white blood cells (WBCs) were hematological parameters found to be highly elevated in RA patients, whereas hemoglobin (Hb) and alkaline phosphatase (ALP) are biochemical parameters that have been demonstrated significantly low in RA patients as compared to healthy. Conclusions: Deferentially expressed parameters ESR, WBCs, Hb, and ALP can be used for the diagnosis of RA.
References
Lin YJ, Anzaghe M, Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020 Apr; 9(4): 880. doi: 10.3390/cells9040880.
Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD et al. Global epidemiology of rheumatoid arthritis. Nature Reviews Rheumatology. 2022 Oct; 18(10): 591-602. doi: 10.1038/s41584-022-00827-y.
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. The Lancet 2016;388:2023-38. 10.1016/S0140-6736(16)30173-8: 10.1016/S0140-6736(16)30173-8
Radu AF and Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021 Oct; 10(11): 2857. doi: 10.3390/cells10112857.
van Delft MA and Huizinga TW. An overview of autoantibodies in rheumatoid arthritis. Journal of Autoimmunity. 2020 Jun; 110: 102392. doi: 10.1016/j.jaut.2019.102392.
Deane KD and Holers VM. Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift. Arthritis & Rheumatology. 2021 Feb; 73(2): 181-93. doi: 10.1002/art.41417.
Liu D, Zhang F, Cao H, Wang X. Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?. Annals of the Rheumatic Diseases. 2022 Mar; 81(3): e36-. doi: 10.1136/annrheumdis-2020-217214.
Krajewska-Włodarczyk M, Szeląg M, Batko B, Żuber Z, Orleański M, Podwójcic K et al. Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology International. 2024 Jun; 44(6): 1155-63. doi: 10.1007/s00296-024-05591-8.
Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatology International. 2021 May; 41(5): 863-77. doi: 10.1007/s00296-020-04731-0.
Naqvi AA, Hassali MA, Naqvi SB, Kachela B, Khan I. Estimation of direct cost of managing rheumatoid arthritis treatment to Pakistani patients using real‐world follow‐up data. International Journal of Rheumatic Diseases. 2020 Mar; 23(3): 325-33. doi: 10.1111/1756-185X.13776.
Aletaha D and Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. Jama. 2018 Oct; 320(13): 1360-72. doi: 10.1001/jama.2018.13103.
Visser H, Le Cessie S, Vos K, Breedveld FC, Hazes JMJA, Rheumatism. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. 2002;46:357-65.
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Research. 2018 Apr; 6(1): 15. doi: 10.1038/s41413-018-0016-9.
Stepanov A, Radocha J, Matuskova V. Blood Diseases. Ocular Manifestations of Systemic Diseases: Springer. 2024; 23-77. doi: 10.1007/978-3-031-58592-0_2.
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Research. 2018 Apr; 6(1): 15. doi: 10.1038/s41413-018-0016-9.
Patel A, Bhatt V, Edara M. A Study of Haematological Profile in Newly Diagnosed Rheumatoid Arthritis and its Correlation with Disease Activity. The Journal of the Association of Physicians of India. 2022 Apr; 70(4): 11-2.
Nikolaisen C, Figenschau Y, Nossent JCJTJor. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. 2008;35:380-6.
Farouk AM, Abdel Rahman SM, Abou Elwafa MA, Aboud FM. Hematological parameters in rheumatoid arthritis and their relationship with disease activity. Ain Shams Medical Journal. 2023 Jun; 74(2): 493-503. doi: 10.21608/asmj.2023.307126.
Li Y, Wu Y, Huang J, Cao X, An Q, Peng Y et al. A variety of death modes of neutrophils and their role in the etiology of autoimmune diseases. Immunological Reviews. 2024 Jan; 321(1): 280-99. doi: 10.1111/imr.13284.
Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G et al. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Frontiers in Immunology. 2022 Dec; 13: 1051082. doi: 10.3389/fimmu.2022.1051082.
Lapić I, Padoan A, Bozzato D, Plebani M. Erythrocyte sedimentation rate and C-reactive protein in acute inflammation: meta-analysis of diagnostic accuracy studies. American Journal of Clinical Pathology. 2020 Jan; 153(1): 14-29. doi: 10.1093/ajcp/aqz142.
Alende-Castro V, Alonso-Sampedro M, Vazquez-Temprano N, Tuñez C, Rey D, García-Iglesias C et al. Factors influencing erythrocyte sedimentation rate in adults: new evidence for an old test. Medicine. 2019 Aug; 98(34): e16816. doi: 10.1097/MD.0000000000016816.
El Ridi R and Tallima H. Physiological functions and pathogenic potential of uric acid: A review. Journal of Advanced Research. 2017 Sep; 8(5): 487-93. doi: 10.1016/j.jare.2017.03.003.
Nada D, Gaber R, Mahmoud AS, Elkhouly R, Alashkar D. Hyperuricemia among Egyptian rheumatoid arthritis patients. Is it an association or an inflammatory marker? A cross-sectional observational study. Open Access Rheumatology: Research and Reviews. 2021 Oct: 305-14. doi: 10.2147/OARRR.S331488.
Sokolova MV, Schett G, Steffen U. Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clinical reviews in allergy & immunology. 2022 Oct; 63(2): 138-51. doi: 10.1007/s12016-021-08890-1.
Zhang H, Yang G, Jiang R, Feng D, Li Y, Chen Y et al. Correlation between total bilirubin, total bilirubin/albumin ratio with disease activity in patients with rheumatoid arthritis. International Journal of General Medicine. 2023 Dec: 273-80. doi: 10.2147/IJGM.S393273.
Juping D, Yuan Y, Shiyong C, Jun L, Xiuxiu Z, Haijian Y et al. Serum bilirubin and the risk of rheumatoid arthritis. Journal of Clinical Laboratory Analysis. 2017 Nov; 31(6): e22118. doi: 10.1002/jcla.22118.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments